Ballentine Partners’s Smith & Wesson SWBI Stock Holding History

Ballentine Partners’s Portfolio SWBI Stock Details SWBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-17,588	Closed	-$173K	–	1082
2025 Q3	$173K	Buy	+17,588	New	+$150K	﹤0.01%	941

Other funds holding SWBI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Ballentine Partners's SWBI Position: Q4 2025 in Review

Ballentine Partners sold out of Smith & Wesson (SWBI) in Q4 2025, closing a stake of 17,588 shares — an estimated $173K sold.

Ballentine Partners first reported a position in SWBI in Q3 2025 and held it in 1 quarter. The position peaked at $173K in Q3 2025. 169 funds tracked by Wall St. Rank hold SWBI as of Q4 2025.

Ballentine Partners reported no remaining Smith & Wesson position as of Q4 2025 after selling out during the quarter.
Ballentine Partners sold 17,588 Smith & Wesson shares in Q4 2025, an estimated $173K.
Ballentine Partners first reported a position in Smith & Wesson in Q3 2025 and held it in 1 quarter.
Ballentine Partners's Smith & Wesson position peaked at $173K in Q3 2025.
169 funds tracked by Wall St. Rank held Smith & Wesson as of Q4 2025.

Based on Ballentine Partners's 13F filing for Q4 2025, filed 3 Feb 2026.